Insider · CIK 0001201039

BAILES JOSEPH S

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001201039

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,142 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,016 sh	—	—	0
2023-11-27	Harpoon Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+31.4K sh	$1.40	+$44K	31,428
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2020-03-30	Harpoon Therapeutics, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,335
2003-11-20	ILEX ONCOLOGY INCStock Option (right to buy)A Award	Director	AAward	+3,000 sh	$19.71	+$59.1K	3,000
2003-08-08	US ONCOLOGY INCS Sale	Executive Vice President	SSale	−50K sh	$7.56	−$378K	14,993
2003-08-08	US ONCOLOGY INCD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−50K sh	$7.56	−$378K	14,993
2002-12-04	ILEX ONCOLOGY INCOption to BuyA Award	Director	AAward	+6,000 sh	—	—	—
2002-12-04	ILEX ONCOLOGY INCCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	—
2001-12-17	ILEX ONCOLOGY INCCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	—
2000-11-30	ILEX ONCOLOGY INCCommon StockD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	—

Recent filings

Accepted (ET)
Mar 114
BAILES JOSEPH S0000950170-24-029429
SEC(opens sec.gov)
Nov 284
BAILES JOSEPH S0001209191-23-056793
SEC(opens sec.gov)
Jun 234
BAILES JOSEPH S0001209191-23-039401
SEC(opens sec.gov)
Jun 244
BAILES JOSEPH S0001209191-22-039322
SEC(opens sec.gov)
May 144/A
BAILES JOSEPH S0001209191-21-032968
SEC(opens sec.gov)
May 74
BAILES JOSEPH S0001209191-21-031109
SEC(opens sec.gov)
Apr 14
BAILES JOSEPH S0001209191-20-022196
SEC(opens sec.gov)
Nov 244
BAILES JOSEPH S0001209191-03-031784
SEC(opens sec.gov)
Aug 184/A
BAILES JOSEPH S0001225208-03-000404
SEC(opens sec.gov)
Aug 124
BAILES JOSEPH S0001225208-03-000377
SEC(opens sec.gov)
Jan 174
BAILES JOSEPH S0000950134-03-000813
SEC(opens sec.gov)

Companies

Address

C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080